182 related articles for article (PubMed ID: 1848172)
1. Lymphocytotoxins in sera from highly sensitized multiparous dialysis patients: antibody class, relationship with the HLA and with paternal antigens.
Propper DJ; Leheny WA; Urbaniak SJ; Catto GR; Macleod AM
Clin Sci (Lond); 1991 Feb; 80(2):87-93. PubMed ID: 1848172
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive lymphocytotoxic IgM antibodies in highly sensitized dialysis patients waiting for a kidney transplant: identification and clinical relevance.
Barocci S; Valente U; Gusmano R; Perfumo F; Cantarella S; Leprini A; Icardi A; Nocera A
Clin Nephrol; 1991 Jul; 36(1):12-20. PubMed ID: 1889147
[TBL] [Abstract][Full Text] [Related]
3. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group.
Hahn AB; Foulks GN; Enger C; Fink N; Stark WJ; Hopkins KA; Sanfilippo F
Transplantation; 1995 Jan; 59(1):21-7. PubMed ID: 7839424
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation.
Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F
J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748
[TBL] [Abstract][Full Text] [Related]
5. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation.
Duquesnoy RJ; White LT; Fierst JW; Vanek M; Banner BF; Iwaki Y; Starzl TE
Transplantation; 1990 Sep; 50(3):427-37. PubMed ID: 2402792
[TBL] [Abstract][Full Text] [Related]
6. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes.
Smith JD; Danskine AJ; Rose ML; Yacoub MH
Transplantation; 1992 Jun; 53(6):1358-62. PubMed ID: 1604491
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
8. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.
Opelz G;
Lancet; 2005 Apr 30-May 6; 365(9470):1570-6. PubMed ID: 15866311
[TBL] [Abstract][Full Text] [Related]
11. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft.
Böhmig GA; Regele H; Säemann MD; Exner M; Druml W; Kovarik J; Hörl WH; Zlabinger GJ; Watschinger B
Am J Kidney Dis; 2000 Apr; 35(4):667-73. PubMed ID: 10739788
[TBL] [Abstract][Full Text] [Related]
12. Kidney graft failure and presensitization against HLA class I and class II antigens.
Süsal C; Opelz G
Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
[TBL] [Abstract][Full Text] [Related]
13. Anti-class II antibody production prolongs renal allograft survival.
Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin class and specificity of lymphocytotoxic antibodies after kidney transplantation.
Marcén R; Ting A; Taylor CJ; Miach PJ; Chapman JR; Morris PJ
Nephrol Dial Transplant; 1988; 3(6):809-13. PubMed ID: 3147425
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytotoxic antibodies in Israeli patients with rheumatoid arthritis.
Livneh A; Renert A; Avishai O; Langevitz P; Gazit E
Isr J Med Sci; 1997 Jan; 33(1):30-5. PubMed ID: 9203515
[TBL] [Abstract][Full Text] [Related]
16. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
17. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
18. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
20. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
